These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 450956)

  • 21. METABOLISM OF BARBITAL BY STREPTOMYCES MEDITERRANEI.
    KLUEPFEL D; LANCINI GC; SARTORI G
    Appl Microbiol; 1965 Jul; 13(4):600-4. PubMed ID: 14339268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A MODIFIED METHOD FOR PREPARING BARBITAL SODIUM].
    ZHONG LX
    Yao Xue Xue Bao; 1962 Jun; 9():380. PubMed ID: 14075908
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential thermal, solubility, and aging studies on various sources of digoxin and digitoxin powder: biopharmaceutical implications.
    Chiou WL; Kyle LE
    J Pharm Sci; 1979 Oct; 68(10):1224-9. PubMed ID: 512850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [On the pharmaceutical technology of film coating (author's transl)].
    Kala H; Dittgen M; Moldenhauer H; Zessin G
    Pharmazie; 1979 Nov; 34(11):755-65. PubMed ID: 397492
    [No Abstract]   [Full Text] [Related]  

  • 25. [COMPLEXOMETRIC DETERMINATION OF BARBITAL].
    CIOGOLEA G; CREANGA S; MIHAI T; PETRONIU L
    Ann Pharm Fr; 1963; 21():681-4. PubMed ID: 14091316
    [No Abstract]   [Full Text] [Related]  

  • 26. [Visco-plastic behavior of powder in the process of dynamic compression (author's transl)].
    Horikoshi I; Morii M; Nakabayashi S; Takeguchi N; Kimura M
    Yakugaku Zasshi; 1979 Apr; 99(4):325-8. PubMed ID: 480130
    [No Abstract]   [Full Text] [Related]  

  • 27. [Crystal grains after casting in Ni-base alloys with low-melting point (author's transl)].
    Wakasa K; Yamaki M
    Hiroshima Daigaku Shigaku Zasshi; 1980; 12(2):271-6. PubMed ID: 6943198
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study on tablets. XX. Further knowledge of powdered and microcrystalline cellulose].
    Heliová M; Chalabala M; Malý J
    Cesk Farm; 1972 Jul; 21(6):261-6. PubMed ID: 5068872
    [No Abstract]   [Full Text] [Related]  

  • 29. Crystal structure of a 1:1 aminopyrine-barbital complex.
    Kiryu S
    J Pharm Sci; 1971 May; 60(5):699-703. PubMed ID: 5125767
    [No Abstract]   [Full Text] [Related]  

  • 30. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.
    Javadzadeh Y; Mohammadi A; Khoei NS; Nokhodchi A
    Acta Pharm; 2009 Jun; 59(2):187-97. PubMed ID: 19564143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Salivary excretion of barbital and diazepam in human (author's transl)].
    Ogata H; Horii S; Shibazaki T; Aoyagi N; Kaniwa N; Ejima A
    Eisei Shikenjo Hokoku; 1978; (96):27-32. PubMed ID: 750039
    [No Abstract]   [Full Text] [Related]  

  • 32. [Possibilities of using a new binding substance in barbital and sodium barbital tablets].
    Zakrzhevskaia TN; Kuiantseva AM; Shatalova NV
    Farmatsiia; 1978; 27(2):19-23. PubMed ID: 640028
    [No Abstract]   [Full Text] [Related]  

  • 33. On the use of x-ray powder patterns for identification of barbiturates in forensic chemistry.
    HUANG TY; JERSLEV B
    Acta Pharmacol Toxicol (Copenh); 1951; 7(3):227-30. PubMed ID: 14856755
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on the phase diagram of aminopyrine-barbital-water system and crystal data of the molecular compound of aminopyrine and barbital].
    Kiryu S; Iguchi S
    Yakugaku Zasshi; 1969 May; 89(5):707-11. PubMed ID: 5818008
    [No Abstract]   [Full Text] [Related]  

  • 35. [Preferred orientation of crystalline particles within tablets. III. Change in degree of preferred orientation of aspirin crystals during compression (author's transl)].
    Nakagawa H; Fukuoka E; Nakai Y
    Yakugaku Zasshi; 1979 Sep; 99(9):936-43. PubMed ID: 547057
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experimental study on development of physical dependence on alcohol and cross physical dependence liability of diazepam and barbital to alcohol in rhesus monkeys (author's transl)].
    Miyasato K
    Seishin Shinkeigaku Zasshi; 1978 Dec; 80(12):657-67. PubMed ID: 108696
    [No Abstract]   [Full Text] [Related]  

  • 37. [Crystal morphological and habit investigations of crystalline drugs. II. Amobarbital, barbital and ephedrine hydrochloride].
    Watanabe A; Ohnuma N
    Yakugaku Zasshi; 1993 Feb; 113(2):159-66. PubMed ID: 8487158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmaceutical granulation technology].
    Dittgen M; Kala H; Moldenhauer H; Zessin G; Schneider J
    Pharmazie; 1980; 35(4):237-49. PubMed ID: 7403250
    [No Abstract]   [Full Text] [Related]  

  • 39. Polymorphism of sulindac: isolation and characterization of a new polymorph and three new solvates.
    Tros de Ilarduya MC; Martín C; Goñi MM; Martínez-Ohárriz MC
    J Pharm Sci; 1997 Feb; 86(2):248-51. PubMed ID: 9040104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of the texture of furosemid tablets. Part 2 (author's transl)].
    Pintye-Hódi K; Szabó-Révész P; Keresztes A; Selmeczi B
    Pharmazie; 1979 Jan; 34(1):51-3. PubMed ID: 432257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.